Beatrix Bartók

3.7k citations
42 papers · 2.8k · 3 hit papers · h-index 17

Impact in

  • Rheumatology top 0.5%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Hematology top 2%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Rheumatoid Arthritis Research and Therapies 21
    • Chronic Lymphocytic Leukemia Research 19
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 6

Beatrix Bartók

41 papers receiving 2.8k citations

Beatrix Bartók's Hit Papers

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial 2021 · 173 citations
1730+5+11Years since publication50010001.5k

Peers

Beatrix Bartók
Comparison fields: 5 of 100
  • Rheumatology 1.2k
  • Hematology 361
  • Immunology 570
  • Genetics 218
  • Cancer Research 274
Replace Onno J. Arntz with:
Onno J. Arntz Netherlands
M Tohidast-Akrad Austria
Jean‐Pierre David Germany
Tong Zhou United States
Kary A. Latham United States
W. B. Van Den Berg Netherlands
Jing Luo China
Yi He China
David S. Rubenstein United States
Anne M. Fourie United States
Beatrix Bartók relative to Onno J. Arntz Netherlands Onno J. Arntz's profile →
Citations per field
00.5×1.5×2.3×
Onno J. Arntz · 1×
Citations per year

Countries citing papers authored by Beatrix Bartók

Since Specialization
Citations

This map shows the geographic impact of Beatrix Bartók's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrix Bartók with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrix Bartók more than expected).

Fields of papers citing papers by Beatrix Bartók

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatrix Bartók. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrix Bartók. The network helps show where Beatrix Bartók may publish in the future.

Co-authors

The 25 scholars most cited alongside Beatrix Bartók, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beatrix Bartók Line = papers co-authored together Beatrix Bartók links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Hit paper breakdown →
20091570
2
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy
Hit paper breakdown →
2019230
3
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
Hit paper breakdown →
2021173
4 202199
5 200591
6 201288
7 202168
8 201460
9 200455
10 201550
11 201346
12 200338
13 201334
14 201433
15 201429
16 201925
17 202117
18
Efficacy and Safety of Filgotinib for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate: FINCH1 Primary Outcome Results
201916
19 201914
20 202012

About Beatrix Bartók

Beatrix Bartók is a scholar working on Rheumatology, Genetics, Hematology, Molecular Biology and Pathology and Forensic Medicine, having authored 42 papers that have together received 2.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (21 papers), Chronic Lymphocytic Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Protein Tyrosine Phosphatases (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Autoimmune Bullous Skin Diseases (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Rheumatology (1.2k citations), Hematology (361 citations), Immunology (570 citations), Genetics (218 citations) and Cancer Research (274 citations). Beatrix Bartók has collaborated with scholars based in United States, Japan and Belgium. Frequent co-authors include Gary S. Firestein, F. Matzkies, Ying Guo, Chantal Tasset, John S. Sundy, Neelufar Mozaffarian, David L. Boyle, Mark C. Genovese, Tsutomu Takeuchi and Jacques‐Eric Gottenberg. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Modern Rheumatology, Immunological Reviews and Rheumatology and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact